Presbyopia Drops

As we age, our eyes gradually lose the ability to clearly focus at near distances. This condition is known as presbyopia and an estimated 112 million Americans over age 40 are currently experiencing its effects.1

COMING IN Q3 2020:  EyeFocus™ & EyeFocus+™ are intended for presbyopia. Both formulations were developed in partnership with FOV Tears creator Luis Felipe Vejarano, MD, and contain low concentrations of pilocarpine, phenylephrine, pheniramine and ketorolac.

Pilocarpine HCl 0.302%
Phenylephrine HCl 0.624%
Pheniramine 0.772%
Ketorolac 0.01%
Sterile Ophthalmic Solution

9 mL

Pilocarpine HCl 0.604%
Phenylephrine HCl 0.624%
Pheniramine 0.772%
Ketorolac 0.01%
Sterile Ophthalmic Solution 

9 mL